204 related articles for article (PubMed ID: 12777075)
1. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.
Madsen SJ; Sun CH; Tromberg BJ; Hirschberg H
J Neurooncol; 2003 May; 62(3):243-50. PubMed ID: 12777075
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid.
Madsen SJ; Sun CH; Tromberg BJ; Wallace VP; Hirschberg H
Photochem Photobiol; 2000 Jul; 72(1):128-34. PubMed ID: 10911737
[TBL] [Abstract][Full Text] [Related]
3. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Hirschberg H; Sun CH; Krasieva T; Madsen SJ
Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479
[TBL] [Abstract][Full Text] [Related]
4. The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.
Mathews MS; Angell-Petersen E; Sanchez R; Sun CH; Vo V; Hirschberg H; Madsen SJ
Lasers Surg Med; 2009 Oct; 41(8):578-84. PubMed ID: 19731298
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy.
Madsen SJ; Sun CH; Tromberg BJ; Hirschberg H
Lasers Surg Med; 2001; 29(5):406-12. PubMed ID: 11891728
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids.
Hirschberg H; Sun CH; Tromberg BJ; Yeh AT; Madsen SJ
J Neurooncol; 2004 Dec; 70(3):289-99. PubMed ID: 15662970
[TBL] [Abstract][Full Text] [Related]
7. Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy.
Kamoshima Y; Terasaka S; Kuroda S; Iwasaki Y
Neurol Res; 2011 Sep; 33(7):739-46. PubMed ID: 21756554
[TBL] [Abstract][Full Text] [Related]
8. Repetitive photodynamic therapy of malignant brain tumors.
Hirschberg H; Sørensen DR; Angell-Petersen E; Peng Q; Tromberg B; Sun CH; Spetalen S; Madsen S
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):261-79. PubMed ID: 16566723
[TBL] [Abstract][Full Text] [Related]
9. Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model.
Zelenkov P; Baumgartner R; Bise K; Heide M; Meier R; Stocker S; Sroka R; Goldbrunner R; Stummer W
J Neurooncol; 2007 Mar; 82(1):49-60. PubMed ID: 17004102
[TBL] [Abstract][Full Text] [Related]
10. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro.
Etminan N; Peters C; Lakbir D; Bünemann E; Börger V; Sabel MC; Hänggi D; Steiger HJ; Stummer W; Sorg RV
Br J Cancer; 2011 Sep; 105(7):961-9. PubMed ID: 21863026
[TBL] [Abstract][Full Text] [Related]
11. Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.
Madsen SJ; Mathews MS; Angell-Petersen E; Sun CH; Vo V; Sanchez R; Hirschberg H
J Neurooncol; 2009 Jan; 91(2):141-9. PubMed ID: 18777009
[TBL] [Abstract][Full Text] [Related]
12. Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. Laboratory investigation.
Etminan N; Peters C; Ficnar J; Anlasik S; Bünemann E; Slotty PJ; Hänggi D; Steiger HJ; Sorg RV; Stummer W
J Neurosurg; 2011 Aug; 115(2):281-8. PubMed ID: 21513432
[TBL] [Abstract][Full Text] [Related]
13. ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.
Hirschberg H; Sun CH; Tromberg BJ; Madsen SJ
J Neurooncol; 2002 Mar; 57(1):1-7. PubMed ID: 12125962
[TBL] [Abstract][Full Text] [Related]
14. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model.
Angell-Petersen E; Spetalen S; Madsen SJ; Sun CH; Peng Q; Carper SW; Sioud M; Hirschberg H
J Neurosurg; 2006 Jan; 104(1):109-17. PubMed ID: 16509154
[TBL] [Abstract][Full Text] [Related]
15. [Photodynamic therapy mediated with 5-aminolevulinic acid for C6 glioma spheroids].
Kamoshima Y; Terasaka S; Iwasaki Y
Hokkaido Igaku Zasshi; 2008 May; 83(3):167-73. PubMed ID: 18546870
[TBL] [Abstract][Full Text] [Related]
16. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review).
Friesen SA; Hjortland GO; Madsen SJ; Hirschberg H; Engebraten O; Nesland JM; Peng Q
Int J Oncol; 2002 Sep; 21(3):577-82. PubMed ID: 12168102
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Studies with Glioblastoma Brain Organoid Co-Cultures Show Efficient 5-ALA Photodynamic Therapy.
Pedrosa L; Bedia C; Diao D; Mosteiro A; Ferrés A; Stanzani E; Martínez-Soler F; Tortosa A; Pineda E; Aldecoa I; Centellas M; Muñoz-Tudurí M; Sevilla A; Sierra À; González Sánchez JJ
Cells; 2023 Apr; 12(8):. PubMed ID: 37190034
[TBL] [Abstract][Full Text] [Related]
20. Isolation and initial characterization of human glioblastoma cells resistant to photodynamic therapy.
Vilchez ML; Rodríguez LB; Palacios RE; Prucca CG; Caverzán MD; Caputto BL; Rivarola VA; Milla Sanabria LN
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102097. PubMed ID: 33232818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
